期刊文献+

Fas/FasL、bcl-2、caspase-8在丹皮酚诱导大肠癌细胞凋亡中的相互作用及机制 被引量:9

The correlation of Fas/FasL, bcl-2, caspase-8 in paeonol inducing colorectal cancer cell line HT-29 apoptosis and molecule mechanism
下载PDF
导出
摘要 目的探讨丹皮酚(Paeonol,Pae)诱导人大肠癌HT29细胞凋亡过程中Fas/FasL、bcl-2、caspase8细胞凋亡调节基因的相互关系及可能的作用机制。方法应用透射电镜技术对Pae诱导HT29细胞凋亡进行形态学观察;应用免疫细胞化学技术检测用药前后凋亡相关基因Fas/FasL、caspase-8、bcl-2表达的变化。结果HT29细胞经Pae作用后,在透射电镜下观察到HT29细胞出现典型的细胞凋亡形态;免疫细胞化学结果显示Pae作用后HT29细胞Fas/FasL、caspase-8蛋白表达明显升高,bcl2蛋白表达显著降低。结论Pae能抑制HT29细胞增殖并诱导其凋亡,其作用可能是通过上调Fas/FasL、caspase8蛋白表达,下调bcl2的表达有关。 Objective To investigate the correlation of Fas/FasL, bcl-2, caspase-8 in paeonol (Pae) inhibiting proliferation of HT-29 cells and inducing its apoptosis and the possible molecule mechanism. Methods The morphologiy of apoptosis on HT-29 cells were observed by transmission electron microscopy, The expression of apoptosis associated proteins Fas/ FasL,bcl-2,caspase-8 was measured by immunocytochemical staining. Results Typical apoptosis morphology of HT-29 cells was observed by transmission electron microscopy after treated by Pae, Immunocytochemical staining showed that the expression of Fas/FasL, caspase-8 proteins was increased significantly while the expression of bcl-2 protein was decreased on HT-29 cells after treated by Pae. Conclusion Pae may inhibit HT-29 cells proliferation and induce its apoptosis. The possible mechanism is up-regulation the expression of Fas/FasL, caspase-8 and down-regulation the expression of bcl-2 protein.
出处 《胃肠病学和肝病学杂志》 CAS 2006年第2期194-196,共3页 Chinese Journal of Gastroenterology and Hepatology
基金 湖北省自然基金项目(NO2004ABA243)
关键词 丹皮酚 大肠癌 凋亡 FAS/FASL BCL-2 CASPASE-8 Paeonol Colorectal cancer Apoptosis Fas/FasL bcl-2 caspase-8
  • 相关文献

参考文献8

二级参考文献33

  • 1陈紫榕,刘小朋,张国安,林华,周善建,陈仁英,李龙洋.乙型肝炎、肝癌患者中肿瘤坏死因子的检测[J].上海免疫学杂志,1994,14(2):98-99. 被引量:5
  • 2吴元芳,张雨龙,贺战军,周瑞菊,庄道玲.白细胞介素-2放射免疫测定的临床意义[J].放射免疫学杂志,1996,9(1):50-51. 被引量:7
  • 3章灵华,肖培根,黄艺,钱玉昆.丹皮酚的药理与临床研究进展[J].中国中西医结合杂志,1996,16(3):187-190. 被引量:117
  • 4[6]Nishimura T, Ohta S, Sato N et al. Combination tumor immunotherpy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice. Int J Cancer, 1987; 40(2): 255~61
  • 5[9]Schiller JH, Morgan-Ihrig C, Levitt ML. Concomitant administration of interlenkin-2 plus tumor necrosis factor αin advanced non-small cell lung cancer. Am J Clin Oncol, 1995;18(1):47~51
  • 6Litvak DA, Bilcbik A J, Cabot MC. Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy. J Gastrointest Surg 2003; 7 (1): 140 - 8; discussion 148.
  • 7Keepers YP, Pizao PE, Peters GJ, et al. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer 1991; 27:897 - 900.
  • 8Chung-Faye GA, Kerr DJ, Young LS, et al. Gene therapy strategies for colon cancer. Mol Med Today 2000; 6 (2): 82 - 7.
  • 9Todryk S, Melcher A, Bottley G, et al. Cell death associated with genetic prodrug activation therapy of colorectal cancer. Cancer Letters 2001; 174:25 - 33.
  • 10Chang HL, Hung CF, Yeh CC, et al. Paeonol promoted 2-aminofluorence and p-amiobenzoic acid acetylations by mononuclear leucocytes from Sprague-Dawley rats. Cytobios 2000; 103(404): 149 -58.

共引文献110

同被引文献60

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部